APOA1BP, PGC, HPX, and DDT were discovered to be connected to the risk of gastric disease progression and to be able to forecast the progression of gastric disease in a prospective study on proteomic analysis, GPL, and early gastric cancer (88). This evidence concerns the gene PGC and stomach disorder.